Luis Alvarez/DigitalVision via Getty Images The last few months have unfortunately been a tough time for shareholders of HCA Healthcare ( HCA ). Since I last reaffirmed the company as a ‘buy’ candidate in April of this year, the stock has fallen 11.3%. The S&P 500 is up 5.6% in that same time. Naturally, I am disappointed by this. But I am not deterred. In that article, I mentioned how strong fina...
Luis Alvarez/DigitalVision via Getty Images The last few months have unfortunately been a tough time for shareholders of HCA Healthcare ( HCA ). Since I last reaffirmed the company as a ‘buy’ candidate in April of this year, the stock has fallen 11.3%. The S&P 500 is up 5.6% in that same time. Naturally, I am disappointed by this. But I am not deterred. In that article, I mentioned how strong financial performance had been, with revenue, profits, and cash flows on the rise. And honestly, even though my last article was not exactly spot on, my overall assessment of it in recent years has been. I have had it rated a ‘buy’ consistently since August of 2021. And whenever I rate a company a ‘buy’, I am making the claim that the stock should experience upside that surpasses the market for the foreseeable future. In the time since then, shares are up 77.3%, narrowly outperforming the 70.4% rise that the market enjoyed. Despite the decline in share price, I think that fundamentals for the business continue to improve. The company continues to grow, and shares remain cheap on an absolute basis while being priced around the middle of the group in relation to other similar enterprises. This alone is enough to justify maintaining it as a soft ‘buy’. But this does not mean that I cannot or will not change my opinion as new data comes to the forefront. It just so happens that, in the coming weeks, management will be announcing results for the second quarter of the 2026 fiscal year. And as we approach that date, like on or around July 24th, analysts expect revenue and profitability to both rise. Add on top of this the prospect of continued share repurchases and the payout of dividends to investors, and I don't see any reason that my assessment of it will be proven wrong. Time for a health screening Author - SEC EDGAR Data Since my last article about HCA Healthcare, investors have only been given data covering a single additional operating quarter. That happens to be the first quar...
Former Pemex Chief Executive Officer Victor Rodríguez was detained by authorities in Mexico City’s Benito Juarez borough on Tuesday, outlet El Universal reported citing the National Registry of Detentions. The document did not specify the crime for which Rodríguez was arrested, El Universal said. Rodríguez came under investigation after a video was published online of him brawling with his wife, M...
Former Pemex Chief Executive Officer Victor Rodríguez was detained by authorities in Mexico City’s Benito Juarez borough on Tuesday, outlet El Universal reported citing the National Registry of Detentions. The document did not specify the crime for which Rodríguez was arrested, El Universal said. Rodríguez came under investigation after a video was published online of him brawling with his wife, María Felicia Jiménez. President Claudia Sheinbaum said at the time that no one is above the law and that his appointment to lead Mexico’s National Institute of Electricity and Clean Energies had been canceled. The former CEO resigned from the state-owned oil giant in May, in what Sheinbaum called a planned move. Juan Carlos Carpio, then chief financial officer, was tapped to replace him. Rodríguez did not immediately respond to a request for comment sent late Tuesday.